Dr. Alain Vandormael

Senior Lecturer, School of Nursing and Public Health, UKZN. Multi-disciplinary research interests, including sociology, epidemiology, statistics, and demography.

Contact Details:

Email: avandormael@ahri.org

Telephone: +27 (0) 31 260 3744

Background:

Alain Vandormael was awarded his PhD in Sociology and MSc in Statistics from the University of Minnesota, USA. His PhD examined the preventive and survival benefits of antiretroviral (ART) use in the AHRI study area of Somkhele, northern KwaZulu-Natal. Alain is interested in understanding why some HIV prevention strategies are falling short, and providing insight into how these strategies can be optimized in the future.

Current Affiliations:

- Senior Lecturer: School of Nursing and Public Health, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.

- Research Associate: KWAZULU-NATAL RESEARCH AND INNOVATION SEQUENCING PLATFORM (KRISP)

- Research Associate: AFRICA HEALTH RESEARCH INSTITUTE (AHRI)

Education:

Ph.D. Sociology University of Minnesota, Twin Cities, Sept. 2014

M.S. Statistics University of Minnesota, Twin Cities, February 2014

M.A. Sociology University of Pretoria, South Africa, May 2005

B.A. Psychology University of Pretoria, South Africa, January 2003


Open access pdf Publications

Sexual partnership age pairings and risk of HIV acquisition in rural South Africa.
Akulliana A, Bershteyna A, Kleina D, Vandormael A, Barnighausen T, Tanser F, AIDS (2017), :DOI:10.1097/QAD.0000000000001553.

Incidence rate estimation, periodic testing and the limitations of the mid-point imputation approach.
Vandormael A, Dobra A, Barnighausen T, de Oliveira T, Tanser F, International Journal of Epidemiology (2017), :doi.org/10.1093/ije/dyx134.

CD4+ T-cell count may not be a useful strategy to monitor antiretroviral therapy response in HTLV-1/HIV co-infected patients.
Vandormael A, Rego F, Danaviah S, Alcantara L, Boulware D, de Oliveira T, Current HIV Research (2017), :doi: 10.2174/1570162X15666170216114917.

Social disequilibrium and the risk of HIV acquisition: A multilevel study in rural KwaZulu-Natal Province, South Africa.
Tomita A, Vandormael AM, Barnighausen T, de Oliveira T, Tanser F, J Acquir Immune Defic Syndr. (2017), :10.1097/QAI.0000000000001349.

Pairwise diversity and tMRCA as potential markers for HIV infection recency.
Moyo S, Wilkinson E, Vandormael A, Wang R, Weng J, Kotokwe KP, Gaseitsiwe S, Musonda R, Makhema J, Essex M, Engelbrecht S, de Oliveira T, Novitsky V , Medicine (Baltimore) (2017), 96:doi: 10.1097/MD.0000000000006041.

Analysis of Viral Diversity in Relation to the Recency of HIV-1C Infection in Botswana.
Moyo S, Vandormael A, Wilkinson E, Engelbrecht S, Gaseitsiwe S, Kotokwe, KP, Musonda R, Tanser F, Essex M, Novitsky V, de Oliveira T, PLoS One (2016), 11(8):DOI:10.1371/journal.pone.0160649.

Brief Report: Virologic Monitoring Can Be a Cost-Effective Strategy to Diagnose Treatment Failure on First-Line ART.
Vandormael AM, Boulware DR, Tanser FC, Barnighuasen TW, Stott KE, de Oliveira T, J Acquir Immune Defic Syndr. (2016), 71(4):462?466.

Identifying Recent HIV Infections: From Serological Assays to Genomics.
Moyo S, Wilkinson E, Novitsky V, Vandormael A, Gaseitsiwe S, Essex M, Engelbrecht S, de Oliveira T , Viruses (2015), 7:5508-5524; doi:10.3390/v7102887.

Use of antiretroviral therapy in households and risk of HIV acquisition in rural KwaZulu-Natal, South Africa, 2004-12: a prospective cohort study.
Vandormael A, Newell ML, Barnighausen T, Tanser F, Lancet Global Health (2014), 2:e209-215.

bioafrica - News Section from Bioafrica and SATuRN websitesbioafrica - News Section from Bioafrica and SATuRN websites
News News Description and Link

bioafrica - News Section from Bioafrica and SATuRN websites

KRISP News

KwaZulu-Natal Research and Innovation Sequencing Platform (KRISP) Established

KRISP News - 2017-07-12

The Technology Innovation Agency (TIA) and UKZN have signed an agreement for the establishment of KRISP - the KwaZulu-Natal Research and Innovation Sequencing Platform.


IDSE Infectious Diseases

CD4+ Count Not Useful to Assess ART Response in HTLV-1/HIV Coinfection

IDSE Infectious Diseases - 2017-03-21

Patients coinfected with human T-cell lymphotropic virus 1 (HTLV-1) and HIV continue to have elevated CD4+ T-cell counts, even though there is no difference in their HIV viral load levels after antiretroviral therapy when compared with patients who just have HIV (Curr HIV Res 2017).


EurekaAlert!

CD4+ T-cell count useful to assess antiretroviral therapy response in HTLV-1/HIV patients?

EurekaAlert! - 2017-03-17

News coverage and clinical management implication of our recent HIV/HTLV co-infection manuscript, Current HIV Research, 2017



Page design updated by Tulio de Oliveira, 2015